SG167671A1 - Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2- furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamide - Google Patents

Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2- furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamide

Info

Publication number
SG167671A1
SG167671A1 SG200717017-8A SG2007170178A SG167671A1 SG 167671 A1 SG167671 A1 SG 167671A1 SG 2007170178 A SG2007170178 A SG 2007170178A SG 167671 A1 SG167671 A1 SG 167671A1
Authority
SG
Singapore
Prior art keywords
cyclobuten
aminobenzamide
dioxo
furanyl
propyl
Prior art date
Application number
SG200717017-8A
Other languages
English (en)
Inventor
Jianguo Yin
Xiaoyong Fu
Shuyi Zhang
Timothy L Mcallister
Agnes S Kim-Meade
Jason L Winters
Anantha Sudhakar
Doris P Schumacher
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of SG167671A1 publication Critical patent/SG167671A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG200717017-8A 2003-04-18 2004-04-16 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2- furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamide SG167671A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46377303P 2003-04-18 2003-04-18

Publications (1)

Publication Number Publication Date
SG167671A1 true SG167671A1 (en) 2011-01-28

Family

ID=33310818

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200717017-8A SG167671A1 (en) 2003-04-18 2004-04-16 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2- furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobenzamide

Country Status (13)

Country Link
US (3) US7071342B2 (de)
EP (2) EP1615903B1 (de)
JP (2) JP4440917B2 (de)
CN (3) CN100448860C (de)
AR (1) AR044027A1 (de)
AT (1) ATE457307T1 (de)
CA (1) CA2522748C (de)
DE (1) DE602004025458D1 (de)
ES (1) ES2338657T3 (de)
MX (1) MXPA05011183A (de)
SG (1) SG167671A1 (de)
WO (1) WO2004094398A2 (de)
ZA (3) ZA200508129B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040106794A1 (en) * 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
CA2554709C (en) * 2004-01-30 2011-11-15 Schering Corporation Crystalline polymorphs of a cxc-chemokine receptor ligand
US8183287B2 (en) 2006-06-12 2012-05-22 Schering Corporation Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders
CA2692269A1 (en) * 2007-07-03 2009-01-08 Schering Corporation Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
CA2694268A1 (en) * 2007-07-05 2009-01-08 Schering Corporation Process for controlled crystal size in 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
EP2583960A4 (de) 2010-06-16 2015-07-15 Teijin Ltd Verfahren zur herstellung von zwischenprodukten für eine zyklische carbodiimidverbindung
WO2012147897A1 (ja) * 2011-04-25 2012-11-01 住友化学株式会社 アミン化合物の製造方法
TWI734715B (zh) 2015-11-19 2021-08-01 美商卡默森屈有限公司 趨化因子受體調節劑
TWI724056B (zh) 2015-11-19 2021-04-11 美商卡默森屈有限公司 Ｃｘｃｒ２抑制劑
US11052065B2 (en) 2017-09-27 2021-07-06 Merck Sharp & Dohme Corp. Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist
US11207294B2 (en) 2018-01-08 2021-12-28 Chemocentryx, Inc. Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
TWI849253B (zh) * 2019-11-11 2024-07-21 美商富曼西公司 用於製備3-溴-1- (3-氯吡啶-2-基) -1h-吡唑-5-羧酸乙酯的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076926A1 (en) * 2001-02-02 2002-10-03 Schering Corporation 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
WO2002083624A1 (en) * 2001-04-16 2002-10-24 Schering Corporation 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2791613A (en) * 1953-08-24 1957-05-07 Columbia Southern Chem Corp Metahaloaniline production using copper oxide-chromic oxide catalysts
CH691112A5 (de) 1995-03-14 2001-04-30 Sumitomo Chemical Co Verfahren zur Herstellung von Kristallen eines Schwefelsäuresalzes des 3-Amino-2-hydroxyacetophenons mit hoher Schüttdiche und verbesserten Fliesseigenschaften .
ZA991105B (en) * 1998-03-04 2000-02-11 Searle & Co Synthesis of chiral beta-amino acids.
US20030204085A1 (en) * 2001-02-02 2003-10-30 Taveras Arthur G. 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
US20040106794A1 (en) 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
EP1485089B1 (de) * 2002-03-18 2013-04-17 Merck Sharp & Dohme Corp. Kombinationsbehandlungen für chemokine-bedingte erkrankungen
US12284102B2 (en) 2022-09-01 2025-04-22 Dell Products, L.P. Detection of collaboration sessions and other workloads in a heterogenous computing platform

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076926A1 (en) * 2001-02-02 2002-10-03 Schering Corporation 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
WO2002083624A1 (en) * 2001-04-16 2002-10-24 Schering Corporation 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands

Also Published As

Publication number Publication date
EP2168956B1 (de) 2013-03-20
EP1615903A2 (de) 2006-01-18
ES2338657T3 (es) 2010-05-11
CN1805947A (zh) 2006-07-19
WO2004094398A2 (en) 2004-11-04
EP2168956A2 (de) 2010-03-31
MXPA05011183A (es) 2005-12-14
JP4440917B2 (ja) 2010-03-24
WO2004094398A3 (en) 2005-03-03
ZA200800486B (en) 2009-07-29
US7910775B2 (en) 2011-03-22
US20040209946A1 (en) 2004-10-21
CN101514193A (zh) 2009-08-26
CN100448860C (zh) 2009-01-07
AR044027A1 (es) 2005-08-24
JP5202503B2 (ja) 2013-06-05
CN101514168B (zh) 2014-02-26
EP2168956A3 (de) 2010-07-14
EP1615903B1 (de) 2010-02-10
US7462740B2 (en) 2008-12-09
JP2006523616A (ja) 2006-10-19
DE602004025458D1 (de) 2010-03-25
US20060205961A1 (en) 2006-09-14
CN101514193B (zh) 2012-12-19
US7071342B2 (en) 2006-07-04
US20090048458A1 (en) 2009-02-19
ZA200508129B (en) 2008-04-30
EP2168956B8 (de) 2013-05-01
HK1078315A1 (en) 2006-03-10
CN101514168A (zh) 2009-08-26
CA2522748A1 (en) 2004-11-04
ZA200800487B (en) 2009-08-26
JP2010053139A (ja) 2010-03-11
ATE457307T1 (de) 2010-02-15
CA2522748C (en) 2011-06-28

Similar Documents

Publication Publication Date Title
EP2168956B8 (de) Synthese von 2-hydroxy-n,n-dimethyl-3-[[2-[1(r) - (5-methyl-2-furanyl) propyl] -3, 4-dioxo-1-cyclobuten-1-yl]amino] Benzamid
IL157478A0 (en) Method for the synthesis of 2', 3'-didehydronucleosides
EE05216B1 (et) Pregabaliini asmmeetriline sntees
PL377187A1 (pl) Związki ze skondensowanym pierścieniem 1,3-dihydroimidazolowym
WO2005107462A3 (en) Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
EP1352965A4 (de) Verfahren zur herstellung einer amidverbindung unter verwendung eines mikrobiellen katalysators
HUP0400053A3 (en) New process for synthesis of 4-phenylbutyric acid
PL377519A1 (pl) Związki N-(indoloetylo-)cykloaminowe
EP1499586A4 (de) Neue form von n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanin
AU2003295684A8 (en) Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
IL176131A0 (en) Practical, cost-effective synthesis of ubiquinones
ITMI20000026A0 (it) Procedimento per la produzione di gas di sintesi
IL155578A0 (en) Novel ascorbic acid compounds, methods of synthesis and application use thereof
SI1506203T1 (sl) Sinteza epotilonov, intermediati za to, analogi in njihove uporabe
AU2002331595A1 (en) Novel vasoconstrictor cannabinoid analogs
GB0302465D0 (en) "13C-labelled synthesis"
GB0112322D0 (en) Synthesis of chiral intermediates
GB0115588D0 (en) Novel compounds for use as photoinitiators
AU2002305242A1 (en) Synthesis of carbamate through low pressure heterogeneous oxidative carbonylation of amines
EP1701937A4 (de) Stabile polymorphe von (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamid
AU2002358357A1 (en) Improvements relating to frequency synthesis
PL1644340T3 (pl) N-[({4-podstawione związki piperazyn-1-ylo}sulfonylometylo)alkilo]-n-hydroksyformamidowe jako inhibitory metaloproteinazy
IL161642A0 (en) IMPROVED PURIFICATION OF 4,4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
GB0225106D0 (en) Synthesis of 3 hydroxy-5 -steroids
IL175742A0 (en) Insecticidal n-(heteroarylalkyl) alkanediamine derivatives